Literature DB >> 23026829

Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review.

Marije E Hamaker1, Judith M Jonker, Sophia E de Rooij, Alinda G Vos, Carolien H Smorenburg, Barbara C van Munster.   

Abstract

Comprehensive geriatric assessment (CGA) is done to detect vulnerability in elderly patients with cancer so that treatment can be adjusted accordingly; however, this process is time-consuming and pre-screening is often used to identify fit patients who are able to receive standard treatment versus those in whom a full CGA should be done. We aimed to assess which of the frailty screening methods available show the best sensitivity and specificity for predicting the presence of impairments on CGA in elderly patients with cancer. We did a systematic search of Medline and Embase, and a hand-search of conference abstracts, for studies on the association between frailty screening outcome and results of CGA in elderly patients with cancer. Our search identified 4440 reports, of which 22 publications from 14 studies, were included in this Review. Seven different frailty screening methods were assessed. The median sensitivity and specificity of each screening method for predicting frailty on CGA were as follows: Vulnerable Elders Survey-13 (VES-13), 68% and 78%; Geriatric 8 (G8), 87% and 61%; Triage Risk Screening Tool (TRST 1+; patient considered frail if one or more impairments present), 92% and 47%, Groningen Frailty Index (GFI) 57% and 86%, Fried frailty criteria 31% and 91%, Barber 59% and 79%, and abbreviated CGA (aCGA) 51% and 97%. However, even in case of the highest sensitivity, the negative predictive value was only roughly 60%. G8 and TRST 1+ had the highest sensitivity for frailty, but both had poor specificity and negative predictive value. These findings suggest that, for now, it might be beneficial for all elderly patients with cancer to receive a complete geriatric assessment, since available frailty screening methods have insufficient discriminative power to select patients for further assessment.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23026829     DOI: 10.1016/S1470-2045(12)70259-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  135 in total

Review 1.  Frailty in Hematologic Malignancy.

Authors:  Thuy T Koll; Ashley E Rosko
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

2.  Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma.

Authors:  Karin Ribi; Stéphanie Rondeau; Felicitas Hitz; Ulrich Mey; Milica Enoiu; Thomas Pabst; Anastasios Stathis; Natalie Fischer; Kerri M Clough-Gorr
Journal:  Support Care Cancer       Date:  2017-04-13       Impact factor: 3.603

3.  Frailty Screening Tools for Elderly Patients Incident to Dialysis.

Authors:  Ismay N van Loon; Namiko A Goto; Franciscus T J Boereboom; Michiel L Bots; Marianne C Verhaar; Marije E Hamaker
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-17       Impact factor: 8.237

4.  Prostate cancer: Age is nothing but a number.

Authors:  Mitchell E Gross
Journal:  Nat Rev Urol       Date:  2013-11-12       Impact factor: 14.432

Review 5.  Management of mantle cell lymphoma in the elderly: current and potential strategies.

Authors:  Marguerite Vignon; Marie-Dominique Venon; Olivier Hermine; Richard Delarue
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

6.  Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.

Authors:  Kana Oiwa; Kei Fujita; Shin Lee; Tetsuji Morishita; Hikaru Tsukasaki; Eiju Negoro; Takanori Ueda; Takahiro Yamauchi
Journal:  Oncologist       Date:  2020-12-30

7.  High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.

Authors:  E Schorb; C P Fox; K Fritsch; L Isbell; A Neubauer; A Tzalavras; R Witherall; S Choquet; O Kuittinen; D De-Silva; K Cwynarski; C Houillier; K Hoang-Xuan; V Touitou; N Cassoux; J-P Marolleau; J Tamburini; R Houot; V Delwail; G Illerhaus; C Soussain; B Kasenda
Journal:  Bone Marrow Transplant       Date:  2017-04-24       Impact factor: 5.483

Review 8.  The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer.

Authors:  Marije E Hamaker; Alinda G Vos; Carolien H Smorenburg; Sophia E de Rooij; Barbara C van Munster
Journal:  Oncologist       Date:  2012-08-31

9.  Changes in etiology and severity of dysphagia with aging.

Authors:  Da Hyun Ahn; Hea Eun Yang; Hyo Jung Kang; Kyung Hee Do; Seok Cheol Han; Soo Woong Jang; Jang Ho Lee
Journal:  Eur Geriatr Med       Date:  2019-11-11       Impact factor: 1.710

Review 10.  Management of locally advanced rectal cancer in the elderly: a critical review and algorithm.

Authors:  Lara Hathout; Nell Maloney-Patel; Usha Malhotra; Shang-Jui Wang; Sita Chokhavatia; Ishita Dalal; Elizabeth Poplin; Salma K Jabbour
Journal:  J Gastrointest Oncol       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.